RICHMOND, Va. - The U.S. Centers for Disease Control & Prevention (CDC) confirmed to the Virginia Department of Health (VDH) Tuesday afternoon that it is examining the death of a Virginia woman as part of its investigation into possible adverse side effects from the Johnson & Johnson COVID-19 vaccine.
VDH says the death happened in March. It was reported to the CDC’s Vaccine Adverse Event Reporting System (VAERS), and a report can be found by searching the system for VAERS ID 1114806-1.
No further details will be provided during the investigation.
Earlier Tuesday, the CDC and the U.S. Food and Drug Administration (FDA) called for a pause on the use of the Johnson & Johnson vaccine after six people in the United States developed a rare disorder involving blood clots within about two weeks of vaccination. This pause was recommended out of an abundance of caution, as these adverse events appear to be extremely rare.
To date, VDH says more than 6.8 million people in the United States have received Johnson & Johnson vaccines and six recipients are known to have developed a type of blood clot called cerebral venous sinus thrombosis (CVST) in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination.
The health department says the CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday, April 14, to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.
Virginia announced Tuesday it will stop using the Johnson & Johnson vaccines until this investigation is complete. VDH says this pause is reassuring in that it demonstrates that the systems that are in place to monitor vaccine safety are working.
Health officials say Virginia’s vaccine rollout will continue with the other two authorized vaccines, developed by Pfizer and Moderna.
People who have received the Johnson & Johnson vaccine who develop severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination should contact their health care provider or call 911 if it is a medical emergency.